SOURCE-LINKED STUDY SUMMARY
Safety and Glycemic Efficacy of Perioperative Liraglutide in Cardiac Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
What was studied?
Abstract-based systematic review and meta-analysis pooled randomized trials of perioperative subcutaneous liraglutide versus placebo or insulin-based usual care in adults undergoing cardiac surgery.
What changed?
Liraglutide did not significantly change 30-day mortality, overall postoperative complications, cardiac events, hypoglycemia, or postoperative nausea and vomiting.
Who was studied?
Seven reports from four trials included 446 randomized cardiac-surgery patients; treatment timing and liraglutide doses are not reported in the supplied abstract.
Studied exposure
Not extracted or not reported in this source.
What remains uncertain?
Only four trials were available, and wide confidence intervals—especially for mortality and nausea/vomiting—leave substantial uncertainty around those null estimates.
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1097/crd.0000000000001465